SCHEMBL10639273

SCHEMBL10639273

CN(CC(F)(F)C(F)(F)C(F)(F)F)C(=O)CCc1ccc(CCCCCc2c(C3=CCCC=C3)ccc3cc(O)ccc23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9862588 0.86 ESR1 (0.33) —
SCHEMBL10451506 0.73 HTR5A (0.33) —
SCHEMBL10639909 0.64 ESR1 (0.35) —
SCHEMBL9862532 0.62 ESR1 (0.42) —
SCHEMBL10672680 0.59 — —
SCHEMBL5358039 0.58 ESR1 (0.39) —
SCHEMBL5358409 0.58 ESR1 (0.36) —
SCHEMBL5359670 0.57 ESR1 (0.37) —
SCHEMBL5359563 0.57 ESR1 (0.35) —
SCHEMBL5367335 0.57 ESR1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4760061-A Antioestrogenic agent IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-07-26 — — US disclosed
Send feedback